| Literature DB >> 34907215 |
Maryam Ghafarkhani1, Cigir Biray Avci2, Reza Rahbarghazi3,4, Abbas Karimi5, Majid Sadeghizadeh6, Amir Zarebkohan7,8, Farhad Bani9,10.
Abstract
Unraveling unwanted side effects of nanotechnology-based therapies like photothermal therapy (PTT) is vital in translational nanomedicine. Herein, we monitored the relationship between autophagic response at the transcriptional level by using a PCR array and tumor formation ability by colony formation assay in the human neuroblastoma cell line, SH-SY5Y, 48 h after being exposed to two different mild hyperthermia (43 and 48 °C) induced by PTT. In this regard, the promotion of apoptosis and autophagy were evaluated using immunofluorescence imaging and flow cytometry analyses. Protein levels of Ki-67, P62, and LC3 were measured using ELISA. Our results showed that of 86 genes associated with autophagy, the expression of 54 genes was changed in response to PTT. Also, we showed that chaperone-mediated autophagy (CMA) and macroautophagy are stimulated in PTT. Importantly, the results of this study also showed significant changes in genes related to the crosstalk between autophagy, dormancy, and metastatic activity of treated cells. Our findings illustrated that PTT enhances the aggressiveness of cancer cells at 43 °C, in contrast to 48 °C by the regulation of autophagy-dependent manner.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34907215 PMCID: PMC8671444 DOI: 10.1038/s41598-021-02697-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The concept of this study. May photothermal therapy invoke the tumorigenesis of cancer cells unwantedly by activating the autophagy pathway?
Figure 2Characterization and performance monitoring of synthesized AuNRs. (A) Structural illustration and TEM image of AuNRs and BSA–AuNRs. (B) UV–Vis absorption spectra of CTAB–AuNRs and BSA–AuNRs. (C) Zeta potential of CTAB–AuNRs and (D) BSA–AuNRs were measured using DLS.
Figure 3Modeling of temperature elevation by PTT and MTT assay of nanoparticles. (A) The photothermal profiles of pure water and aqueous dispersions of BSA–AuNRs with 30 ppm of BSA–AuNRs examined using 808-nm laser irradiation with a different power density of 1.4 and 2 W/cm2. (B) Cell viability of CTAB–AuNRs and BSA–AuNRs at different concentrations (5–30 ppm). (C) Relative cell viability in response to 808-nm laser irradiation with a power density of 2 W/cm2 after incubation with or without 30 ppm of BSA–AuNRs cell culture media. One-Way ANOVA and Tukey post hoc analysis. (n = 3) **P < 0.01; ***P < 0.001; ****P < 0.0001.
Figure 4FITC-labeled annexin V/PI apoptosis assay. (A) Flow cytometry evaluation of apoptosis in different groups; Control, 43, and 48 °C (from left to right). (B) The number of alive cells after PTT induction between the mentioned groups (P < 0.01). (C) The number of apoptotic cells after PTT induction between the abovementioned groups (P < 0.0001). (D) The number of necrotic cells after PTT induction in the treated groups (P < 0.0001). One-Way ANOVA and Tukey post hoc analysis (n = 3). **P < 0.01; ***P < 0.001; ****P < 0.0001.
Figure 5Quantitative and qualitative evaluation of autophagy induction. (A,C) Flow cytometry histogram of treated cells in different groups. As were showed in this section, the percentage of positive FITC-conjugated LC3 antibody cells increased from left to right by increasing the induced temperature (P < 0.001). (B) The mean fluorescent intensity of treated groups. Our results showed that in addition to the number of FITC-labeled LC3 antibody-positive cells, the intensity of signals significantly increases by temperature elevation (P < 0.001). (D) Qualitatively evaluation of autophagy by fluorescent microscopy. It was showed that the autophagy levels in the cells increase by induction of PTT. One-Way ANOVA and Tukey post hoc analysis (n = 3). ***P < 0.001.
Figure 6Protein level of Ki-67, P62, and LC3 measured by ELISA and PCR array of 86 genes involved in autophagy machinery. (A) Ki-67 protein level (as a proliferation indicator), significantly decreased followed by 43 and 48 °C, which shows the reverse effect of temperature elevation on the cell’s proliferation ability (P < 0.01). (B) LC3 protein level (as autophagy indicator) showed different behavior of cells in response to temperature elevation (P < 0.0001). (C) Interestingly, our results showed that the P62 protein level does not change significantly in response to temperature increase. (D) Phylogenic tree of 86 genes related to autophagy. Our results showed that 54 genes from those changed in response to the PTT. One-Way ANOVA and Tukey post hoc analysis (n = 3). **P < 0.01; ***P < 0.001; ****P < 0.0001.
Figure 7Tumor formation assay. (A) A–E images show the colony formation ability in response to two different PTT regimens, in the presence and absence of HCQ, qualitatively. (B) Statistical analysis of colony formation assay shows that human neuroblastoma cell line behavior completely different in response to 43 and 48 °C. In the former, autophagy has a protective role in cancer cells fate (P < 0.05), while in the latter, autophagy exerts a cytotoxic effect on cancer cells (P < 0.001). One-Way ANOVA and Tukey post hoc analysis. (n = 3). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
Autophagic genes involved in the tumorigenesis process VS our findings.
| Gene expression changes | Cellular outcome | Effect(s) | Consequences on tumor fate | References | Our study findings | |
|---|---|---|---|---|---|---|
| 43 °C | 48 °C | |||||
| Activation of GABARAPL1 | Autophagy activation | Increase ROS | Tumor suppression | [ | NSC | |
| Deletion of damaged Mitochondria | ||||||
| ATG5 | Autophagy inhibition | Oxidative stress | Tumor suppression | [ | ||
| ATG7 (deletion) | Damaged Mitochondria | |||||
| Autophagy activation | ATG4D over-expression | Intracellular LC3-B/P62 accumulation | Tumor suppression | [ | ||
| Autophagosome formation abortion | ||||||
| Atg4B (over-expression) | Autophagy inhibition | LC3-PE degradation | Tumor suppressive | [ | − | |
| LC3 sequestration in the cytosol | ||||||
| DNA damage | Atg4a | Autophagy activation | Tumor suppression by p53-mediated apoptosis | [ | NSC | |
| Atg4c | NSC | |||||
| p53 (activation) | NSC | |||||
| UVRAG up-regulation | Autophagy deficiency | – | Tumor suppression | [ | NSC | |
| Autophagy deficiency | ATG5 and ATG12 deficiency | Decreased survival capacity to metabolic stress | Tumor suppression (Decrease in colonization and survival capability) | [ | ||
| NSC | NSC | |||||
| Dormancy activation | P53 overexpression induced by Cdkn1b | Pentose phosphate pathway destruction | Cell death | [ | NSC | |
| Increased ROS | Dormancy induction by IFN-b | |||||
| ER stress | K-RAS dependent Eif2ak3−/− MEFs | The decrease in VCIP and PDGFRB (angiogenic stabilizer) | Tumor suppression | [ | ||
| ECM destruction | ||||||
| Vast hemorrhage | ||||||
| Autophagy manipulation | eIF4E/eIF4GI knockdown | The decrease in ERα, SMAD5, NFkB, CyclinD1, c-MYC, and HIF1α | The decrease in EMT promoter | [ | ||
| Increase in EMT inhibitors | ||||||
| The decrease in migration capability | ||||||
| HSPA8(HSC70) complex formation | Chaperone mediated autophagy (CMA) | Cargo delivery to the lysosome | Tumor protection by autophagy | [ | NSC | |
| IFN-γ/STAT1 activation | Downregulation of Cyclin E, A, D1,2,3 | Downregulation of CDK4 and CDK6 | Cell cycle arrest | [ | NSC | |
| Cancer cell dormancy | ||||||
| AMBRA1 | AMBRA1 role in the modulation of C-MYC phosphorylation and stability | Intracellular switch between autophagy and apoptosis | Colony formation | [ | NSC | |
| Autophagic survival | ||||||
| Inherent ATG5 or autophagy KO | These mutations may contribute to cancer development by deregulating the autophagy process | Intracellular inherent autophagy | Recurrence, Chemotherapy desensitization | [ | ||
| Increase of dormancy frequency | ||||||
| CTSB | BID knockdown resulted in strong suppression of CPT-induced apoptosis and a shift of cell death towards autophagy | CTSB is one of the hub genes for dormancy | Dormancy hub gene, Survival | [ | ||
| Self-renewal | ||||||
| Increase of Beclin 1 and MAP I LC3 cellular content | CTSB and uPAR regulate the self-renewal properties of glioma stem cells | Metastasis | ||||
| CXCR4 activation | High CXCR4 expression | SDF-1α-CXCR4 signaling on autophagy induction | Promoted cancer cell survival under stress | [ | NSC | |
| Increases autophagic activity | ||||||
| FADD | FADD is also implicated in cell cycle progression, proliferation, and tumorigenesis | FADD in tumor progression via Rheb-mTORC1 pathway in breast cancer | Atg5 contributes to autophagic cell death by interacting with (FADD) | [ | ||
| NFKB1 | Increased activation of NF-κB and MAPK via NFKB1 deletion enhance macrophage and myofibroblast content at the repair | Cross-talk between ER stress, autophagy, apoptosis, and the NF-κB pathways controls the fate of cancer cells | NF-κB inhibition partly enhances the survival of cancer cells following BFA treatment | [ | NSC | |
| Driving increased collagen deposition and biomechanical properties | ||||||
| SNCA | SNCA binds to (HMGB1) blocks HMGB1-BECN1 binding, and strengthens BECN1-BCL2 binding | Deregulation of these molecular events by SNCA overexpression leads to autophagy | Tumor survival | [ | NSC | |
| TGM2 | Putative tumor suppressor in the TP53 pathway and colony formation | Autophagy and CDKN1A-mediated cell cycle arrest | Tumor suppressor | [ | NSC | |
| HGS | Critical role in the recycling and degradation of membrane receptors | Phosphorylation of SMAD1/5/8 and TAK1/p38 to transduce BMP signaling | Tumor survival and invasion | [ | ||
| HGS-dependent TP53 exosome formation | ||||||
Significant values are in bold. NSC non significant change.
Autophagic genes involved in cell death (autophagic or apoptotic) VS our findings.
| Gene expression changes | Cellular outcome | Effect(s) | Consequences on tumor fate | References | Our study findings | |
|---|---|---|---|---|---|---|
| 43 °C | 48 °C | |||||
| Dormancy activation | P53 overexpression induced by Cdkn1b | Pentose phosphate pathway destruction | Cell death | [ | NSC | |
| Increased ROS | Dormancy induction by IFN-b | |||||
| FasL (CD95L or CD178), TRAIL and TNF-α activation | DISC formation | Caspase-3, 6 and 7 activation | Directly cell death | [ | ||
| Bid change into tBid | Mitochondria dependent apoptotic cell death | − | ||||
| − | ||||||
| Autophagy inhibition | ATG7 depletion | Accumulation of damaged mitochondria | The killing of dormant cells | [ | NSC | |
| Increase of ROS | Does not affect cell metastasis and proliferation | |||||
| Increase of apoptosis | ||||||
| Autophagy activation | TMEM166 overexpression | High LC3II/LC3I | Autophagy and apoptosis regulator (autophagic and apoptotic cell death) | [ | ||
| Vacuolization | ||||||
| Mitochondria membrane permeabilization | ||||||
| GABARAPL2/ULK upregulation | Necessary to maturation of two layers membranous vesicles | Shrinkage of tumor volume in complex with ULK2 | Apoptotic cancer cell death | [ | ||
| IRGM KO | p47 dependent GTPase | Negative regulation of IFN signaling | Inhibition of autophagic cell death | [ | NSC | |
| ATG16L2 | Methylation of ATG16L2 | Downregulation of autophagy | Autophagic cancer cell death | [ | ||
| Patients survival | ||||||
| Inherent ATG5 or autophagy KO | Autophagy deficiency | – | Increase apoptotic cell death | [ | ||
| Increase of Bax and Bak1 | Intrinsic pathway of apoptosis (mitochondria) | Indirectly effect on autophagy by inactivation of BaK1 and Bax | Increase cancer cell apoptosis | [ | ||
| Bid and PUMA (apoptosis-associated genes) | BID acts as molecular link between apoptosis and autophagy | Contribute to identifying the molecular mechanism by which autophagy drives cells to death | Autophagic cell death | [ | ||
| PUMA is certain substrate for CMA | ||||||
| DAPK1 | One of the most important genes in intra/extra cellular apoptotic pathways | ARHI dependent | Tumor suppressor | [ | ||
| Apoptotic cell death | ||||||
| PTEN | Negative regulator of PI3K/AKT/mTORC1 | Autophagy activation, PI3K/Akt inhibition, PI3K/AKT/mTORC1 inhibition | Tumor suppressor | [ | ||
| PTEN | Indirectly positive autophagy regulator | PTEN inhibitors (Tsc1 or Tsc2, p27) and Foxo3a | Escape from dormancy | [ | ||
| PTEN | Tumor suppressor | Apoptosis modulators DRAM, DAPk and DRP-1, PTEN, E93, Akt/PKB, and mTOR), Bcl-2 family proteins, TRAIL and beclin 1 | Autophagy act as upstream control of apoptosis death | [ | ||
| GAA deficiency | Lysosomal hydrolysis of glycogen to glucose (glycogen storage disease II, or Pompe) | Accumulation of abnormal proteins and organelles due to inhibition of autophagy | Cell death | [ | NSC | |
| Autophagy abortion | DRAM1 overexpression | By p53 | Apoptotic death | [ | ||
Significant values are in bold. NSC non significant change.
Autophagic genes involved in invasion (colonization, proliferation, tumor formation, promotion, metastasis) VS our findings.
| Gene expression changes | Cellular outcome | Effect(s) | Consequences on tumor fate | References | Our study findings | |
|---|---|---|---|---|---|---|
| 43 °C | 48 °C | |||||
| ATG5 and ATG7- RAS | Increased autophagy | Mitochondria activation | Tumor formation | [ | ||
| NSC | ||||||
| ATG16L1 | Autophagy deficiency | Oxidative stress | Tumor suppression | [ | ||
| LC3-II degradation | Damaged mitochondria | |||||
| Inflammation induction (1β, IL-18) | ||||||
| Autophagy activation | p27Kip1 coaded by CDKN1B | CDK-dependent kinase inhibitor | Tumor promotion | [ | ||
| Autophagy deactivation | ATG3/7/p62 targeting | Pfkfb3 normal expression | Tumor re-proliferation | [ | NSC | NSC |
| NSC | ||||||
| STAT1 inhibition | p27 (CDKN1B), p21(CDKN1A) upregulation | Increase in IDO1 and Kyn receptors | Tumor dormancy | [ | ||
| Rb hypophosphorylation | Increase in colony formation | |||||
| Suppress E2F transcription factor activity | Decrease in proliferation | |||||
| AMBRA1 | AMBRA1 role in the modulation of C-MYC phosphorylation and stability | Intracellular switch between autophagy and apoptosis | Colony formation | [ | NSC | |
| ATG9B mutation | Autophagy suppression | Blocked recruitment of p62-associated ubiquitinated protein for autophagosome–lysosome degradation | Tumorigenesis | [ | ||
| GABARAPL1 down-regulation | Disruption of the intracellular transport of receptors and the autophagy pathway | Low GABARAPL1 expression was correlated with a high risk of metastasis | Metastasis | [ | NSC | |
| ATG10 up-regulation | Acts as an E2-like enzyme that catalyzes the conjugation of ATG12 to ATG5 and increased autophagy | Lymphovascular invasion | Metastasis | [ | ||
| RAB24 over-expression | Promote the EMT, adhesion and vasculogenic effects | Promotes the malignant phenotype | Tumor growth, metastasis, EMT activation | [ | ||
| ATG5 frameshift mutations | Features of cancers with microsatellite instability (MSI) | Common in gastric and colorectal carcinomas | Tumor development by autophagy deregulation | [ | ||
| CTSB | Dormancy hub gene | Strong biomarker for GBM patient’s survival | Tumor progression | [ | ||
| Metastasis | ||||||
| CXCR4 activation | Independent prognostic factor for disease relapse and survival in acute myeloid leukemia (AML) patients | Increases autophagic activity and decreases | Survival | [ | NSC | |
| Colony formation | ||||||
| Cytarabine-induced apoptosis | Proliferation | |||||
| IGF-1 activation | Activated protein kinase B (AKT) | Inhibit autophagy | Induce apoptosis in drug resistant cells | [ | ||
| INS over-expression | Precursor of insulin | Insulin signaling and the regulation of autophagy are relevant to neurodegenerative disorders | Survival | [ | ||
| MAPK8 | Integration point of proliferation, differentiation, transcription regulation and development | Indispensable for TNF superfamily 10 (TNFSF)-induced autophagy | Tumor promotion | [ | NSC | |
| Survival | ||||||
| PIK3CG | Catalytic subunit of class I PI3Ks | Up-regulated under stress conditions | Cell remodeling and tissue failure | [ | ||
| MAPK14 | Activation of MAPK14 impairs autophagosome–lysosome fusion | Phosphorylates ATG5 at threonine 75 | Survival promoting autophagy | [ | ||
| Cell proliferation | ||||||
| Migration, Resistance to apoptosis | ||||||
| RPS6KB1 | In response to mTOR | Autophagy inhibition | Promote protein synthesis | [ | NSC | |
| Cell growth | ||||||
| Cell proliferation | ||||||
| DRAM2 | Is a lysosomal protein | DRAM2 overexpression induced cell migration proteins including RAC1, RHOA, RHOC, ROCK1, and decreased RHOB expression | Metastasis | [ | NSC | |
| Proliferation | ||||||
| Migration | ||||||
| Cell cycle activation | ||||||
| LAMP1 | LAMP1 is lysosomal marker | LAMP1 overexpression reversed the antitumor effects of UBL4A in pancreatic cancer | Cell proliferation | [ | ||
| Migration | ||||||
| Invasion | ||||||
| mTOR | Key regulator of protein synthesis via 4EBP1 and p70S6K1/2 phosphorylation | Increases the translational capacity of cancer cells | Autophagy inhibition | [ | ||
| Dormancy | ||||||
| Metastasis | ||||||
| RPLP0 | Belongs to the L10P family of ribosomal proteins | Affected p21 expression | Cell promotion | [ | NSC | |
| Induction | Autophagy induction (Survival) in response to RPLP deficiency stress | |||||
| G1 arrest of gastric cancer cells | ||||||
| CTSS | Is a lysosomal cysteine protease that may participate in the degradation of antigenic proteins | Cleaves some extracellular matrix (ECM) proteins | Tumorigenesis stimulation | [ | NSC | |
| Metastasis | ||||||
| ESR1 | Point mutations on ESR1 are drivers for resistance, and promote of ERα without the bound ligand | Ligand independently ER stimulation | Proliferation | [ | ||
| Long-distance metastasis | ||||||
| Autophagy manipulation | eIF4E/eIF4GI knockdown | The decrease in ERα, SMAD5, NFkB, CyclinD1, c-MYC, and HIF1α | The decrease in EMT promoter | [ | ||
| Increase in EMT inhibitors | ||||||
| The decrease in migration capability | ||||||
Significant values are in bold. NSC non significant change.